✨ Medicine Consent Notices
NEW ZEALAND GAZETTE, No. 83 — 30 JULY 2015
Product:
Active Ingredient:
Gemcitabine hydrochloride 1138.52mg equivalent to Gemcitabine 1000mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Gemcitabine Dr Reddy’s
Product:
Active Ingredient:
Gemcitabine hydrochloride 2277mg equivalent to Gemcitabine 2000mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Dr Reddy’s New Zealand Limited
Manufacturer:
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Gemcitabine Dr Reddy’s
Product:
Active Ingredient:
Ibrutinib 140mg
Dosage Form:
Capsule
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Catalent CTS Inc, Missouri, United States of America
Imbruvica
Product:
Active Ingredients:
Paracetamol 1000mg
Phenylephrine hydrochloride 12.2mg equivalent to Phenylephrine 10mg
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Reckitt Benckiser (New Zealand) Limited
Manufacturer:
Reckitt Benckiser Healthcare (UK) Limited, Yorkshire, United Kingdom
Lemsip Max Cold & Flu with Decongestant Hot Drink
Product:
Active Ingredient:
Baclofen 0.05mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland
Lioresal Intrathecal
Product:
Active Ingredient:
Baclofen 2mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland
Lioresal Intrathecal
Product:
Active Ingredient:
Sevelamer carbonate 800mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturer:
Genzyme Ireland Limited, Waterford, Ireland
Renvela
Product:
Active Ingredient:
Sevelamer carbonate 1600mg
Dosage Form:
Powder for oral suspension
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturers:
Genzyme Ireland Limited, Waterford, Ireland
Genzyme Limited, Suffolk, United Kingdom
Renvela
Product:
Active Ingredient:
Sevelamer carbonate 2400mg
Dosage Form:
Powder for oral suspension
New Zealand Sponsor:
sanofi-aventis new zealand limited
Manufacturers:
Genzyme Ireland Limited, Waterford, Ireland
Genzyme Limited, Suffolk, United Kingdom
Renvela
Dated this 23rd day of July 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go4407
Consent to the Distribution of New Medicines
44
Next Page →
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare23 July 2015
Medicines, Distribution, Gemcitabine, Dr. Reddy’s, Ibrutinib, Paracetamol, Phenylephrine, Baclofen, Sevelamer
- Chris James, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2015, No 83